BioSpace News Archive

Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with solid and hematological cancers and other serious diseases, today announced that updated infection data on omidubicel in comparison to umbilical cord blood transplantation (UCB), was shared in an oral presentation at the 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings.

The development of the global general laboratory equipment market is anticipated to be influenced by increased research activities in biotechnological and pharmaceutical industries.

Remarkable growth in cases of diabetic retinopathy is projected to fuel expansion avenues in the global widefield imaging systems market during the tenure of 2020 to 2030.

Albany NY, United States: Transparency Market Research has published a new report titled, “neurorehabilitation devices market”.

The University of Tokyo and Astellas Pharma Inc. entered the second phase of their collaboration for co-creating innovative new medicines and medical solutions, called the Astellas Alliance Acceleration Program.

Illumina, Inc. announced an agreement with Germany’s Hannover Medical School to implement the use of whole-genome sequencing in critically ill children suspected of having a genetic or rare disease.

Immunic, Inc. announced participation in the following, upcoming investor and industry conferences:

Albany NY, United States: Government as well as non-government groups are promoting the understanding of the condition and thus are likely to encourage growth of the global multiple sclerosis drugs market.

Albany NY, United States: CRISPR cas systems are commonly used in microbial engineering that includes immunization of cultures, bacterial strain typing, and self-targeted cell killing.

Computational biology has emerged as a discipline in its own right and has enriched the armamentarium of researchers studying molecular mechanism underlying wide range of diseases.